文献速递主动脉疾病

国际血管登记联盟报告:65岁以下腹主动脉瘤治疗存在显著国际差异

International Clinical Practice Variations in Abdominal Aortic Aneurysm Treatment among Patients under 65 Years of Age: a Report from the International Consortium of Vascular Registries.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2025-11-10

该研究通过国际血管登记联盟收集11国2014至2019年完整腹主动脉瘤修复数据,分析65岁以下患者治疗方式、合并症、瘤径及围术期死亡的国际差异。94 833例患者中12 682例(13.4%)年龄<65岁,各国占比8.6%至25.6%不等,EVAR使用率24.9%至74.0%不等,三分之一患者瘤径低于指南推荐阈值。

要点

  • 65岁以下AAA患者占比存在显著国际差异(8.6%-25.6%,p<.001)
  • EVAR使用率国家间差异大(24.9%-74.0%),且与总体EVAR使用强相关(r=0.88)
  • 三分之一患者瘤径低于指南推荐阈值,OAR较EVAR围术期死亡率更高(1.4% vs 0.3%)

核心结论

  • 尽管国际血管学会AAA指南相似,65岁以下患者的管理仍存在显著国际差异,尤其在治疗方式、瘤径阈值和结局方面。
  • 需要更密切评估国际实践模式和指南依从性差距。

研究设计与样本

  • 基于国际血管登记联盟的注册登记研究,收集11个国家(澳大利亚、美国、丹麦、匈牙利、芬兰、冰岛、瑞士、新西兰、挪威、瑞典、英国)2014至2019年完整AAA的开放修复和EVAR登记数据。
  • 共纳入94 833例患者,其中12 682例(13.4%)年龄<65岁,评估治疗方式、合并症、AAA直径和围术期死亡的差异。

主要发现

  • 65岁以下患者占比存在显著国际差异,范围从8.6%(瑞典、英国)至25.6%(匈牙利),p<.001。
  • 65岁以下患者中EVAR占59.6%,各国差异显著(24.9%丹麦至74.0%美国)。
  • EVAR总体使用率与65岁以下患者中EVAR使用率强相关(相关系数=0.88,p<.001)。
  • 三分之一患者瘤径低于指南推荐阈值:男性36.5%,女性29.3%。
  • EVAR可能性随年龄增加而增加,年轻患者中差异最明显;OAR患者AAA更大(5.9 vs 5.6 cm,p<.001)且围术期死亡率更高(1.4% vs 0.3%,p<.001)。

临床怎么用

  • 临床医生应关注65岁以下AAA患者治疗方式选择的国际差异,结合指南和患者年龄评估EVAR与OAR的利弊。
  • 需注意部分患者瘤径低于指南推荐阈值即接受治疗,应加强指南依从性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Societal guidelines recommend risk assessment before elective abdominal aortic aneurysm (AAA) treatment, including consideration of age. Long term durability concerns for endovascular aneurysm repair (EVAR) suggest that age should influence the choice between open aortic repair (OAR) and EVAR. This study aimed to identify international variability in treatment strategies for AAA patients aged < 65 years. METHODS: OAR and EVAR registry data for intact AAAs from 2014 to 2019 were collected from 11 countries (Australia, USA, Denmark, Hungary, Finland, Iceland, Switzerland, New Zealand, Norway, Sweden, and UK) via the International Consortium of Vascular Registries. Variations in treatment modality, comorbidities, AAA diameter, and peri-operative death were assessed. RESULTS: Of 94 833 patients, 12 682 (13.4%) were aged < 65 years, with statistically significant international variation (range, 8.6% [Sweden, UK] - 25.6% [Hungary], p < .001). EVAR was performed in 59.6% of patients aged < 65 years, with considerable variation across countries (range, 24.9% [Denmark] - 74.0% [USA]). The use of EVAR in general is strongly correlated with its use among patients aged < 65 years (correlation coefficient = 0.88, p < .001). One third of the patients were treated below guideline recommended diameter thresholds: 36.5% of men and 29.3% of women. The likelihood of EVAR increased with age, with variations most pronounced among the youngest patients. Compared with patients who underwent EVAR, those who underwent OAR had statistically significantly larger AAAs (5.9 vs. 5.6 cm, p < .001) and a higher peri-operative mortality rate (1.4 vs. 0.3%, p < .001). CONCLUSION: Despite similar AAA guidelines from international vascular societies, substantial variability exists in AAA management for patients aged < 65 years, particularly regarding treatment modality, diameter thresholds, and outcomes. Closer evaluation of international practice patterns and gaps in guideline adherence is needed.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Møller CM, Johal AS, Pherwani AD, et al. International Clinical Practice Variations in Abdominal Aortic Aneurysm Treatment among Patients under 65 Years of Age: a Report from the International Consortium of Vascular Registries. Eur J Vasc Endovasc Surg. 2025. PMID: 41223934. doi:10.1016/j.ejvs.2025.11.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。